Analysts Set Spire Healthcare Group Plc (SPI) Price Target at $311.50
Spire Healthcare Group Plc (LON:SPI) has been assigned a consensus recommendation of “Hold” from the seven analysts that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is GBX 311.50 ($4.19).
A number of research firms have commented on SPI. Jefferies Group decreased their target price on shares of Spire Healthcare Group from GBX 350 ($4.71) to GBX 259 ($3.49) and set a “hold” rating on the stock in a research note on Monday, September 25th. Liberum Capital decreased their target price on shares of Spire Healthcare Group from GBX 365 ($4.91) to GBX 350 ($4.71) and set a “hold” rating on the stock in a research note on Thursday, August 31st. Berenberg Bank restated a “hold” rating and set a GBX 270 ($3.63) target price on shares of Spire Healthcare Group in a research note on Thursday, September 21st. Numis Securities restated an “add” rating and set a GBX 350 ($4.71) target price on shares of Spire Healthcare Group in a research note on Thursday, September 14th. Finally, J P Morgan Chase & Co decreased their target price on shares of Spire Healthcare Group from GBX 376 ($5.06) to GBX 339 ($4.56) and set a “neutral” rating on the stock in a research note on Friday, September 15th.
Shares of Spire Healthcare Group (LON:SPI) traded up GBX 4.10 ($0.06) during trading hours on Thursday, hitting GBX 245.60 ($3.31). 1,299,664 shares of the stock traded hands, compared to its average volume of 2,300,000. Spire Healthcare Group has a 52-week low of GBX 218.20 ($2.94) and a 52-week high of GBX 362.10 ($4.87).
The firm also recently announced a dividend, which will be paid on Tuesday, December 12th. Investors of record on Thursday, November 16th will be issued a GBX 1.30 ($0.02) dividend. This represents a dividend yield of 0.5%. The ex-dividend date is Thursday, November 16th.
In other news, insider Peter R. Bamford acquired 5,000 shares of the company’s stock in a transaction on Monday, November 27th. The stock was bought at an average cost of GBX 240 ($3.23) per share, with a total value of £12,000 ($16,150.74). Also, insider Justin Ash acquired 89,100 shares of the company’s stock in a transaction on Friday, September 29th. The shares were purchased at an average cost of GBX 224 ($3.01) per share, with a total value of £199,584 ($268,619.11). Over the last three months, insiders purchased 178,600 shares of company stock valued at $41,184,900.
TRADEMARK VIOLATION WARNING: This story was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/12/05/analysts-set-spire-healthcare-group-plc-spi-price-target-at-311-50.html.
About Spire Healthcare Group
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Stock Ratings for Spire Healthcare Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group Plc and related stocks with our FREE daily email newsletter.